Cargando…
MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro
Elite controllers maintain HIV-1 viral loads below the limit of detection. The mechanisms responsible for this phenomenon are poorly understood. As microRNAs (miRNAs) are regulators of gene expression and some of them modulate HIV infection, we have studied the miRNA profile in plasma from HIV elite...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118195/ https://www.ncbi.nlm.nih.gov/pubmed/25081906 http://dx.doi.org/10.1038/srep05915 |
_version_ | 1782328803408740352 |
---|---|
author | Reynoso, Rita Laufer, Natalia Hackl, Matthias Skalicky, Susanna Monteforte, Rossella Turk, Gabriela Carobene, Mauricio Quarleri, Jorge Cahn, Pedro Werner, Roland Stoiber, Heribert Grillari-Voglauer, Regina Grillari, Johannes |
author_facet | Reynoso, Rita Laufer, Natalia Hackl, Matthias Skalicky, Susanna Monteforte, Rossella Turk, Gabriela Carobene, Mauricio Quarleri, Jorge Cahn, Pedro Werner, Roland Stoiber, Heribert Grillari-Voglauer, Regina Grillari, Johannes |
author_sort | Reynoso, Rita |
collection | PubMed |
description | Elite controllers maintain HIV-1 viral loads below the limit of detection. The mechanisms responsible for this phenomenon are poorly understood. As microRNAs (miRNAs) are regulators of gene expression and some of them modulate HIV infection, we have studied the miRNA profile in plasma from HIV elite controllers and chronically infected individuals and compared against healthy donors. Several miRNAs correlate with CD4+ T cell count or with the known time of infection. No significant differences were observed between elite controllers and healthy donors; however, 16 miRNAs were different in the plasma of chronic infected versus healthy donors. In addition, levels of hsa-miR-29b-3p, hsa-miR-33a-5p and hsa-miR-146a-5p were higher in plasma from elite controllers than chronic infected and hsa-miR-29b-3p and hsa-miR-33a-5p overexpression significantly reduced the viral production in MT2 and primary T CD4+ cells. Therefore, levels of circulating miRNAs might be of diagnostic and/or prognostic value for HIV infection, and hsa-miR-29b-3p and miR-33a-5p may contribute to the design of new anti-HIV drugs. |
format | Online Article Text |
id | pubmed-4118195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-41181952014-08-15 MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro Reynoso, Rita Laufer, Natalia Hackl, Matthias Skalicky, Susanna Monteforte, Rossella Turk, Gabriela Carobene, Mauricio Quarleri, Jorge Cahn, Pedro Werner, Roland Stoiber, Heribert Grillari-Voglauer, Regina Grillari, Johannes Sci Rep Article Elite controllers maintain HIV-1 viral loads below the limit of detection. The mechanisms responsible for this phenomenon are poorly understood. As microRNAs (miRNAs) are regulators of gene expression and some of them modulate HIV infection, we have studied the miRNA profile in plasma from HIV elite controllers and chronically infected individuals and compared against healthy donors. Several miRNAs correlate with CD4+ T cell count or with the known time of infection. No significant differences were observed between elite controllers and healthy donors; however, 16 miRNAs were different in the plasma of chronic infected versus healthy donors. In addition, levels of hsa-miR-29b-3p, hsa-miR-33a-5p and hsa-miR-146a-5p were higher in plasma from elite controllers than chronic infected and hsa-miR-29b-3p and hsa-miR-33a-5p overexpression significantly reduced the viral production in MT2 and primary T CD4+ cells. Therefore, levels of circulating miRNAs might be of diagnostic and/or prognostic value for HIV infection, and hsa-miR-29b-3p and miR-33a-5p may contribute to the design of new anti-HIV drugs. Nature Publishing Group 2014-08-01 /pmc/articles/PMC4118195/ /pubmed/25081906 http://dx.doi.org/10.1038/srep05915 Text en Copyright © 2014, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Reynoso, Rita Laufer, Natalia Hackl, Matthias Skalicky, Susanna Monteforte, Rossella Turk, Gabriela Carobene, Mauricio Quarleri, Jorge Cahn, Pedro Werner, Roland Stoiber, Heribert Grillari-Voglauer, Regina Grillari, Johannes MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro |
title | MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro |
title_full | MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro |
title_fullStr | MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro |
title_full_unstemmed | MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro |
title_short | MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro |
title_sort | micrornas differentially present in the plasma of hiv elite controllers reduce hiv infection in vitro |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118195/ https://www.ncbi.nlm.nih.gov/pubmed/25081906 http://dx.doi.org/10.1038/srep05915 |
work_keys_str_mv | AT reynosorita micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT laufernatalia micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT hacklmatthias micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT skalickysusanna micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT monteforterossella micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT turkgabriela micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT carobenemauricio micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT quarlerijorge micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT cahnpedro micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT wernerroland micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT stoiberheribert micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT grillarivoglauerregina micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro AT grillarijohannes micrornasdifferentiallypresentintheplasmaofhivelitecontrollersreducehivinfectioninvitro |